Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Empower Clinics Inc
(OP:
EPWCF
)
N/A
UNCHANGED
Last Price
Updated: 9:50 AM EDT, Oct 11, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
500
Open
-
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
0.0001
Today's Range
N/A - N/A
52wk Range
0.0001 - 0.0001
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Marijuana Stock Movers For October 11, 2023
October 11, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 2, 2023
October 02, 2023
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Performance
More News
Read More
Empower Clinics Provides Corporate Update
August 18, 2023
Via
ACCESSWIRE
Empower Clinics Provides Corporate Update
May 19, 2023
Via
ACCESSWIRE
Empower Clinics Provides Corporate Update
May 09, 2023
Via
ACCESSWIRE
CORRECTION: Empower Clinics Reports Q4 2022 Results
February 28, 2023
Via
ACCESSWIRE
Empower Clinics Announces Closing of Second Tranche Private Placement Financing
August 15, 2023
Via
ACCESSWIRE
The Power Play by The Market Herald Releases New Interviews with Beyond Oil, Empower Clinics and Nextech3D.ai Discussing Their Latest News
August 09, 2023
Via
ACCESSWIRE
Empower Clinics Announces Closing of First Tranche Private Placement Financing
August 09, 2023
Via
ACCESSWIRE
Empower Clinics Announces Proposal For Division Spin Out
August 01, 2023
Via
ACCESSWIRE
Empower Clinics Signs New Agreements To Advance Growth Of Research and Clinical Trials with Signing Of Two Additional Principal Investigators - And Are Approved To Process Multiple Clinical Study Applications From Pharmaceutical Sponsors
July 31, 2023
Via
ACCESSWIRE
Empower Clinics Reports Q4 2022 Results
February 28, 2023
Via
ACCESSWIRE
Empower Clinics Announces Proposed Private Placement
June 23, 2023
Via
ACCESSWIRE
Empower Clinics Announces Share Consolidation
June 19, 2023
Via
ACCESSWIRE
Empower Clinics Signs Letter of Intent for $5 Million Equity Capital Facility and Provides Additional Corporate Updates
June 06, 2023
Via
ACCESSWIRE
Empower Clinics Advances Research and Clinical Trials Division with The Signing of Another Experienced Principal Investigator
May 03, 2023
Via
ACCESSWIRE
Empower Clinics Accelerates Growth of Research and Clinical Trials Division with Signing of Two Additional Principal Investigators at First Site in Dallas, Texas
April 25, 2023
Via
ACCESSWIRE
Empower Clinics Announces Official Launch of Mobile Technology & Communications Platform, PulseIR Powered by Fobi
April 20, 2023
Via
ACCESSWIRE
Empower Clinics Signs Agreement To Conduct Research and Clinical Trials with Dallas, TX Based Medical Center - And Major Milestone With Signing Of Research Services Agreement With First Principal Investigator
April 17, 2023
Via
ACCESSWIRE
Empower Clinics Announces Exploration of Strategic Alternatives
March 21, 2023
Via
ACCESSWIRE
Empower Clinics Cancels Previously Announced Private Placement
March 20, 2023
Via
ACCESSWIRE
Empower Clinics Advances Partnership to Launch US Clinical Trial Management Services with Formation of Delaware Based Company and Identification of Principal Investigators
March 07, 2023
Via
ACCESSWIRE
CORRECTION: Empower Clinics Announces FOBI Partnership To Elevate Investor Relations With Digital, Mobile and Personalized Engagement
February 27, 2023
Via
ACCESSWIRE
Empower Clinics Signs Letter of Intent for Partnership to Launch US Clinical Trial Management Services for Biotech and Pharmaceutical Industries
February 07, 2023
Via
ACCESSWIRE
Empower Clinics Announces FOBI Partnership to Elevate Investor Relations with Digital, Mobile and Personalized Engagement
February 02, 2023
Via
ACCESSWIRE
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.